Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in ...

On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026TRX319 is an allogeneic CAR-Tr1 Treg cell therapy designed to pair ...
Hosted on MSN

Stem cell transplant without toxic preparation successfully treats genetic disease

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a Phase I clinical trial has shown.
news.ucsc

State funds stem cell research facility at UC Santa Cruz

The California Institute for Regenerative Medicine (CIRM) has approved a $2.7 million grant to fund a stem cell research facility at UC Santa Cruz. The facility will be shared by UCSC researchers ...
The American Journal of Managed Care

Stem Cell Transplant Offers Hope for Children With Severe Monogenic IBD

Allogeneic HSCT achieved 92% sustained, medication-free remission and 100% survival in children with monogenic IBD, highlighting its potential as a transformative treatment. Monogenic IBD, ...

Inspired by Her Beloved Grandma's Health Journey, a Stem Cell Nurse Saves the Life of a Stranger (Exclusive)

Emily Coiro is a stem cell nurse in New Jersey. After seeing her grandmother struggle with blood cancer, she decided to ...
UUHC Health Feed

First Successful Allogeneic Stem Cell Transplant Using Deceased Donor in Blood Cancer Clinical Trial

For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University ...